Steven Pascoe

Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging

Neutrophil extracellular traps are associated with disease severity and microbiota diversity in patients with chronic obstructive pulmonary disease

Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trial

COPD Guidelines: A Review of the 2018 GOLD Report

Indacaterol–Glycopyrronium versus Salmeterol–Fluticasone for COPD

Tuberculosis and lung damage: from epidemiology to pathophysiology

Maintenance therapy in COPD: time to phase out ICS and switch to the new LAMA/LABA inhalers?

Inflammatory mechanisms in patients with chronic obstructive pulmonary disease

Nrf2 attenuates inflammatory response in COPD/emphysema: Crosstalk with Wnt3a/β‐catenin and AMPK pathways

Identification of responders to inhaled corticosteroids in a chronic obstructive pulmonary disease population using cluster analysis

Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials

FULFIL Trial: Once-Daily Triple Therapy for Patients with Chronic Obstructive Pulmonary Disease

Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD